AboutPracticesProfessionalsNewsCareers
Professionals
Overview

Directory

Practice areas
Antitrust
Commercial Litigation
Health Care

1300 Eye Street NW
Suite 600
Washington, DC
20005

phone: 202.747.1421
fax: 202.408.7838

Christopher Stomberg, Ph.D.

Principal

Christopher Stomberg has more than 15 years of experience in commercial antitrust litigation, econometric modeling, and quantitative economic analysis. He specializes in the pharmaceutical and health care industries, and also has extensive experience in the agriculture, asbestos, chemicals, computer, security, and telecommunication industries. Dr. Stomberg has assisted in developing several of the custom analytical tools and techniques employed at Bates White, specifically those dealing with the application of statistical and analytical techniques to antitrust and litigation matters.

Prior to joining Bates White, Dr. Stomberg served as an independent Market Research Consultant. Previously, he was the Chief Statistician within the Custom Solutions Group at Computer Intelligence in La Jolla, California. In these roles, Dr. Stomberg led the design, execution, and presentation of analytical solutions for a large number of high-profile B2B market research projects on behalf of many FORTUNE 100 companies. Dr. Stomberg also has consulted for USAID and the World Bank, where he served as a researcher and information specialist.

Ph.D., Economics, University of California, San Diego; M.A., Economics, George Washington University; B.A., Economics, University of Massachusetts, Amherst; Study Abroad, Scandinavian Seminar/Sweden

Back

Areas of expertise

Pharmaceutical and health care litigation

Price-fixing analysis

Merger analysis

Damage estimation

Pharmaceutical marketing portfolio optimization

Econometrics and statistical analysis including artificial neural networks

Christopher Stomberg, Bates White economist, assesses pharmaceutical pre-patent valuation, risks, and hurdles at ACI forum

Chris Stomberg, Bates White economist, discusses pharmaceutical bundling and price transparency at American Conference Institute forum

New Medicaid regulations could force authorized generic drugs out of the market, according to Bates White Principal Chris Stomberg

Dr. Chris Stomberg discussed generic drug competition at Patent Life Cycles conference

Bates White strengthens leadership with appointment of four partners and two principals

Dr. Christopher Stomberg co-authors presentation at leading pharmaceutical conference